Applicant, as named in the Orange Book

Ani Pharms

ANI Pharmaceuticals Inc · Nasdaq: ANIP

Company and ticker: cliffwatch mapping, checked against SEC EDGAR · SEC filings

Next listed expiry: Purified Cortrophin Gel on 27 Oct 2043. 1 products with live protection, 14 without.

Products with listed protection

DrugEarliest generic entry
Purified Cortrophin Gel
NDA 008975
corticotropin
27 Oct 2043
patent

Recent events

Products without listed protection (14)
DrugEarliest generic entry
Arimidex
NDA 020541
anastrozole
open now
no listed protection
Atacand
NDA 020838 · 4 strengths
candesartan cilexetil
open now
no listed protection
Atacand Hct
NDA 021093 · 3 strengths
candesartan cilexetil; hydrochlorothiazide
open now
no listed protection
Brethine
NDA 017849 · 2 strengths
terbutaline sulfate
open now
no listed protection
Casodex
NDA 020498
bicalutamide
open now
no listed protection
Cortenema
NDA 016199
hydrocortisone
open now
no listed protection
Inderal La
NDA 018553 · 4 strengths
propranolol hydrochloride
open now
no listed protection
Innopran Xl
NDA 021438 · 2 strengths
propranolol hydrochloride
open now
no listed protection
Lithobid
NDA 018027
lithium carbonate
open now
no listed protection
Luvox
NDA 021519 · 3 strengths
fluvoxamine maleate
open now
no listed protection
Promethazine Hydrochloride And Dextromethorphan Hydrobromide
NDA 011265
dextromethorphan hydrobromide; promethazine hydrochloride
open now
no listed protection
Reglan
NDA 017854 · 2 strengths
metoclopramide hydrochloride
open now
no listed protection
Vancocin Hydrochloride
NDA 050606 · 2 strengths
vancomycin hydrochloride
open now
no listed protection
Veregen
NDA 021902
sinecatechins
open now
no listed protection